tradingkey.logo
tradingkey.logo
Search

Lyell Immunopharma Inc

LYEL
Add to Watchlist
14.300USD
-1.340-8.57%
Close 11-13 16:00(ET)
350.49MMarket Cap
LossP/E TTM

Ownership

Shareholding Stats

Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
ARCH Venture Partners
13.92%
Innovative Cellular Therapeutics Holdings Ltd
8.14%
Explore Investments LLC
6.55%
Gates Frontier, L.L.C.
6.55%
GSK plc
6.48%
Other
58.35%
Shareholders
Shareholders
Proportion
ARCH Venture Partners
13.92%
Innovative Cellular Therapeutics Holdings Ltd
8.14%
Explore Investments LLC
6.55%
Gates Frontier, L.L.C.
6.55%
GSK plc
6.48%
Other
58.35%
Shareholder Types
Shareholders
Proportion
Corporation
34.08%
Investment Advisor
23.51%
Venture Capital
18.37%
Private Equity
6.92%
Hedge Fund
2.50%
Investment Advisor/Hedge Fund
1.97%
Individual Investor
1.39%
Research Firm
0.63%
Pension Fund
0.14%
Other
10.48%

Institutional Shareholding

Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
256
13.43M
57.58%
+1.89M
2025Q4
254
10.68M
50.29%
+30.20K
2025Q3
260
9.93M
51.69%
-303.37K
2025Q2
273
11.42M
73.88%
-621.28K
2025Q1
284
16.50M
76.82%
-316.09K
2024Q4
285
234.38M
80.23%
+17.13M
2024Q3
284
205.56M
78.25%
-10.65M
2024Q2
276
225.77M
86.93%
-4.87M
2024Q1
265
225.53M
87.01%
-3.27M
2023Q4
256
223.66M
89.04%
+190.31K
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
ARCH Venture Partners
3.25M
13.93%
+488.09K
+17.69%
Mar 06, 2026
Innovative Cellular Therapeutics Holdings Ltd
1.90M
8.15%
+1.90M
--
Nov 06, 2025
Explore Investments LLC
1.04M
4.47%
+1.04M
--
Jul 25, 2025
Gates Frontier, L.L.C.
1.04M
4.47%
+1.04M
--
Jul 25, 2025
GSK plc
1.51M
6.49%
--
--
Dec 31, 2025
Foresite Capital Management, LLC
1.28M
5.48%
--
--
Dec 31, 2025
MWG Management, Ltd.
1.01M
4.33%
--
--
Sep 30, 2025
Milky Way Investments Group Ltd
1.01M
4.33%
+1.01M
--
Dec 31, 2025
Orland Properties Ltd
754.70K
3.24%
--
--
Dec 31, 2025
View more

ETFs

Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
ProShares Ultra Nasdaq Biotechnology
0.06%
Invesco Nasdaq Biotechnology ETF
0.03%
iShares Biotechnology ETF
0.01%
Schwab U.S. Small-Cap ETF
0.01%
Invesco RAFI US 1500 Small-Mid ETF
0.01%
Fidelity Nasdaq Composite Index ETF
0%
iShares Russell 3000 ETF
0%
iShares Russell 2000 Value ETF
0%
Global X Russell 2000 Covered Call ETF
0%
Nuveen ESG Small-Cap ETF
0%
View more
ProShares Ultra Nasdaq Biotechnology
Proportion0.06%
Invesco Nasdaq Biotechnology ETF
Proportion0.03%
iShares Biotechnology ETF
Proportion0.01%
Schwab U.S. Small-Cap ETF
Proportion0.01%
Invesco RAFI US 1500 Small-Mid ETF
Proportion0.01%
Fidelity Nasdaq Composite Index ETF
Proportion0%
iShares Russell 3000 ETF
Proportion0%
iShares Russell 2000 Value ETF
Proportion0%
Global X Russell 2000 Covered Call ETF
Proportion0%
Nuveen ESG Small-Cap ETF
Proportion0%
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.